SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000912057-00-040541
Filing Date
2000-09-08
Accepted
2000-09-08 00:00:00
Documents
14
Period of Report
2000-08-25
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k.txt 8-K 7846
2 EX-4.1 ex-4_1.txt EX-4.1 40283
3 EX-4.2 ex-4_2.txt EX-4.2 28313
4 EX-4,3 ex-4_3.txt EX-4.3 27998
5 EX-4.4 ex-4_4.txt EX-4.4 28006
6 EX-4.5 ex-4_5.txt EX-4.5 53035
7 EX-4.6 a2024779zex-4_6.txt EX-4.6 40447
8 EX-4.7 a2024779zex-4_7.txt EX-4.7 40539
9 EX-4.8 a2024779zex-4_8.txt EX-4.8 27306
10 EX-4.9 a2024779zex-4_9.txt EX-4.9 27930
11 EX-4.10 a2024779zex-4_10.txt EX-4.10 51593
12 EX-10.1 a2024779zex-10_1.txt EX-10.1 162038
13 EX-10.2 a2024779zex-10_2.txt EX-10.2 159220
14 EXHIBIT 99.1 a2024779zex-99_1.txt EX-99.1 6387
  Complete submission text file 0000912057-00-040541.txt   703829
Mailing Address
Business Address 375 WEST STREET WEST BRIDGEWATER MA 02379 5085801900
BOSTON BIOMEDICA INC (Filer) CIK: 0000830656 (see all company filings)

IRS No.: 042652826 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21615 | Film No.: 718813
SIC: 2835 In Vitro & In Vivo Diagnostic Substances